Heart Failure, Sudden Cardiac Arrest, Sudden Death, Ventricular Dysfunction, Ventricular Fibrillation, Ventricular Tachycardia
Conditions
Keywords
wearable cardioverter defibrillator, LifeVest, sudden death, defibrillator
Brief summary
Background: The wearable cardioverter defibrillator (WCD) is an established treatment option for patients at high risk for ventricular tachycardia / ventricular fibrillation (VT/VF), either in whom this risk may only be temporarily present, or in patients at high risk for sudden cardiac death (SCD) or after VT/VF in whom an implantable cardioverter defibrillator (ICD is currently not possible for other reasons (infection, recent MI \<40days, recent PCI/CABG \< 3months etc.). Methods: Comprehensive registry including all patients in Austria who received a WCD in 2010-2016.
Detailed description
Observational study to describe WCD indications, event rates, inappropriate shock rates and follow up (including ICD rate, shock rate, morbidity and mortality) in all Austrian WCD patients
Interventions
OTHERRegistry
Observational study to describe WCD indications, event rates, inappropriate shock rates and follow up (including ICD rate, shock rate, morbidity and mortality) in all Austrian WCD patients
Sponsors
Medical University of Graz
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* patients, with a prescribed WCD according to guidelines in an austrian center
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of participants treated with WCD-treated ventricular arrhythmias | during WCD wearing period; average of 1 year | Number of participants treated with WCD-treated ventricular arrhythmias |
Countries
Austria
Contacts
Primary ContactDaniel Scherr, Assoz. Prof.
Outcome results
None listed